Botulinum toxin for the treatment of movement disorders.
about
Botulinum Toxin for Neuropathic Pain: A Review of the LiteratureApplications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative DiseasesTreatment of dystonia.Closed-loop brain-machine-body interfaces for noninvasive rehabilitation of movement disordersLong-term efficacy and safety of botulinum toxin injections in dystonia.OnabotulinumtoxinA injections in chronic migraine, targeted to sites of pericranial myofascial pain: an observational, open label, real-life cohort study.Botulinum Toxin for the Treatment of Neuropathic Pain.Adverse events associated with botulinum toxin injection: a multidepartment, retrospective study of 5310 treatments administered to 1819 patients.Flu-like symptoms and associated immunological response following therapy with botulinum toxins.The Effect of Botulinum Neurotoxin Serotype a Heavy Chain on the Growth Related Proteins and Neurite Outgrowth after Spinal Cord Injury in Rats.
P2860
Q26796604-A23F3585-2E37-4BE8-9E67-40A9F087B336Q26799331-3C85F0C4-F1C4-4CA9-8F1E-1D9E09209467Q30566734-852D2C07-B02C-4248-A227-CF2358F0A322Q33906026-174D6EB1-5BD2-4D83-A481-E5EC4B1AD106Q36807185-5196C2BD-5EBE-4998-B396-1BF472ED6A88Q38373498-C92ADC6E-63D8-4562-9507-9E6CBD8DE0FAQ41669358-4AFAF4B4-8F49-4A04-9D95-3690C5E9E1BFQ43539225-B99E5DA8-C2FF-480F-9F92-954637023F71Q43736034-9FE23BBC-D977-4AE6-BCC0-9340AF2918C8Q49375875-6E2354CC-B8FA-4F96-86A9-10F1462EE7CE
P2860
Botulinum toxin for the treatment of movement disorders.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Botulinum toxin for the treatment of movement disorders.
@en
type
label
Botulinum toxin for the treatment of movement disorders.
@en
prefLabel
Botulinum toxin for the treatment of movement disorders.
@en
P2860
P1476
Botulinum toxin for the treatment of movement disorders.
@en
P2093
Mary Ann Thenganatt
P2860
P2888
P304
P356
10.1007/S11910-012-0286-3
P50
P577
2012-08-01T00:00:00Z
P6179
1034688976